These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy. Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323 [TBL] [Abstract][Full Text] [Related]
4. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338 [TBL] [Abstract][Full Text] [Related]
5. Comparison of perfused volume segmentation between cone-beam CT and Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960 [TBL] [Abstract][Full Text] [Related]
6. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison. Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346 [TBL] [Abstract][Full Text] [Related]
7. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of imaging Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282 [TBL] [Abstract][Full Text] [Related]
9. Planning dosimetry for Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882 [TBL] [Abstract][Full Text] [Related]
10. An In-House 3D Voxel Dosimetric Tool to Compare Predictive and Post- Treatment Dosimetry in Ferrando O; Bampi R; Foppiano F; Ciarmiello A Curr Radiopharm; 2023 Jun; 16(3):214-221. PubMed ID: 36790008 [TBL] [Abstract][Full Text] [Related]
11. Debebe SA; Adjouadi M; Gulec SA; Franquiz J; McGoron AJ J Appl Clin Med Phys; 2019 Feb; 20(2):30-42. PubMed ID: 30628156 [TBL] [Abstract][Full Text] [Related]
12. Comparative dosimetry between Jadoul A; Bernard C; Lovinfosse P; Gérard L; Lilet H; Cornet O; Hustinx R Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):828-837. PubMed ID: 31388721 [TBL] [Abstract][Full Text] [Related]
13. Quantitative comparison of pre-therapy Knešaurek K; Tuli A; Pasik SD; Heiba S; Kostakoglu L Eur J Radiol; 2018 Dec; 109():57-61. PubMed ID: 30527312 [TBL] [Abstract][Full Text] [Related]
14. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387 [TBL] [Abstract][Full Text] [Related]
15. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT. Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581 [TBL] [Abstract][Full Text] [Related]
16. PET-CT post therapy dosimetry in radioembolization with resin Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres. Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137 [TBL] [Abstract][Full Text] [Related]
18. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing Noipinit N; Sukprakun C; Siricharoen P; Khamwan K Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421 [TBL] [Abstract][Full Text] [Related]
19. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996 [TBL] [Abstract][Full Text] [Related]
20. The superior predictive value of Smits MLJ; Dassen MG; Prince JF; Braat AJAT; Beijst C; Bruijnen RCG; de Jong HWAM; Lam MGEH Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):798-806. PubMed ID: 31399801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]